Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	212
Overall Study	STARTED	2.5 mg Tadalafil	209
Overall Study	STARTED	5 mg Tadalafil	212
Overall Study	STARTED	10 mg Tadalafil	216
Overall Study	STARTED	20 mg Tadalafil	209
Overall Study	Received Double-Blind Study Drug	Placebo	211
Overall Study	Received Double-Blind Study Drug	2.5 mg Tadalafil	208
Overall Study	Received Double-Blind Study Drug	5 mg Tadalafil	212
Overall Study	Received Double-Blind Study Drug	10 mg Tadalafil	216
Overall Study	Received Double-Blind Study Drug	20 mg Tadalafil	209
Overall Study	COMPLETED	Placebo	185
Overall Study	COMPLETED	2.5 mg Tadalafil	182
Overall Study	COMPLETED	5 mg Tadalafil	182
Overall Study	COMPLETED	10 mg Tadalafil	175
Overall Study	COMPLETED	20 mg Tadalafil	162
Overall Study	NOT COMPLETED	Placebo	27
Overall Study	NOT COMPLETED	2.5 mg Tadalafil	27
Overall Study	NOT COMPLETED	5 mg Tadalafil	30
Overall Study	NOT COMPLETED	10 mg Tadalafil	41
Overall Study	NOT COMPLETED	20 mg Tadalafil	47

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00384930/flow